Abstract
e13550 Background: Increased exposure to sunitinib is associated with improved outcome. Preclinical data shows promising antitumor activity of intermittent exposure to high sunitinib concentrations...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
